Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 720
Filter
Add more filters

Complementary Medicines
Publication year range
1.
Front Immunol ; 15: 1381340, 2024.
Article in English | MEDLINE | ID: mdl-38633246

ABSTRACT

Background: In addition to abnormal liver inflammation, the main symptoms of non-alcoholic steatohepatitis (NASH) are often accompanied by gastrointestinal digestive dysfunction, consistent with the concept of spleen deficiency (SD) in traditional Chinese medicine. As an important metabolic sensor, whether peroxisome proliferator-activated receptor alpha (PPARα) participates in regulating the occurrence and development of NASH with SD (NASH-SD) remains to be explored. Methods: Clinical liver samples were collected for RNA-seq analysis. C57BL/6J mice induced by folium sennae (SE) were used as an SD model. qPCR analysis was conducted to evaluate the inflammation and metabolic levels of mice. PPARα knockout mice (PPARαko) were subjected to SE and methionine-choline-deficient (MCD) diet to establish the NASH-SD model. The phenotype of NASH and the inflammatory indicators were measured using histopathologic analysis and qPCR as well. Results: The abnormal expression of PPARα signaling, coupled with metabolism and inflammation, was found in the results of RNA-seq analysis from clinical samples. SD mice showed a more severe inflammatory response in the liver evidenced by the increases in macrophage biomarkers, inflammatory factors, and fibrotic indicators in the liver. qPCR results also showed differences in PPARα between SD mice and control mice. In PPARαko mice, further evidence was found that the lack of PPARα exacerbated the inflammatory response phenotype as well as the lipid metabolism disorder in NASH-SD mice. Conclusion: The abnormal NR signaling accelerated the vicious cycle between lipotoxicity and inflammatory response in NAFLD with SD. Our results provide new evidence for nuclear receptors as potential therapeutic targets for NAFLD with spleen deficiency.


Subject(s)
Non-alcoholic Fatty Liver Disease , PPAR alpha , Animals , Mice , Inflammation , Mice, Inbred C57BL , Mice, Knockout , Non-alcoholic Fatty Liver Disease/genetics , Non-alcoholic Fatty Liver Disease/metabolism , PPAR alpha/metabolism , Spleen/metabolism , Spleen/pathology
2.
Oxid Med Cell Longev ; 2023: 1983616, 2023.
Article in English | MEDLINE | ID: mdl-36798685

ABSTRACT

Background: Spleen deficiency diarrhea (SDD) is a common Traditional Chinese Medicine (TCM) gastrointestinal condition, the causes of which include dysfunction of the intestinal barrier and microbiota. Rice water-fried Atractylodis Rhizoma (RAR) is a commonly used drug to treat this condition, but its mechanism remains unclear. This study explored the related mechanisms of ethanolic extract of rice water-fried Atractylodis Rhizoma (EAR) in the treatment of SDD by examining changes in the intestinal microbiota. Method: Wistar rats were randomly divided into 4 groups including the control, model, EAR low, and high-dose groups, 6 rats in each group. All rats, except the control group, were induced to develop SDD by a bitter-cold purgation method with rhubarb. The therapeutic effect of EAR on SDD was evaluated by pathological sections, inflammatory indicators (TNF-α, IL-1ß, and IL-10), gastrointestinal-related indicators (GAS, DAO, D-lactate, VIP, and SIgA), and intestinal flora (bacteria and fungi) analysis. Results: The results showed that the developed SDD rat model (model group) showed weight loss, decreased food intake, and increased fecal moisture content. Compared with those of the control group, the levels of TNF-α, IL-1ß, DAO, D-lactate, and VIP in the model group were significantly increased, but the levels of IL-10, GAS and SIgA were significantly decreased (p < 0.05). However, the indicators were significantly improved after EAR treatment, indicating that EAR maintained the balance of pro- and anti-inflammatory cytokines and reduced gastric emptying, thereby protecting intestinal barrier function, alleviating intestinal mucosal injury, and relieving SDD by regulating the release of neurotransmitters. EAR was also shown to prevent infection by promoting the accumulation of noninflammatory immunoglobulin SIgA and improving intestinal mucosal immunity to inhibit the adhesion of bacteria, viruses, and other pathogens. Intestinal microbiome analysis showed that the intestinal bacteria and fungi of SDD model rats changed greatly compared with the control group, resulting in intestinal microecological imbalance. The reversal in the composition of the flora after EAR treatment was mainly characterized by a large enrichment of beneficial bacteria represented by Lactobacillus and a decrease in the abundance of potentially pathogenic fungi represented by Aspergillus. Thus, it was speculated that EAR primarily functions to alleviate SDD by increasing the abundance of beneficial bacteria and reducing the abundance of potentially pathogenic fungi. Conclusion: The strong therapeutic effect of EAR on SDD suggests that it is a promising treatment for this condition.


Subject(s)
Atractylodes , Gastrointestinal Microbiome , Oryza , Rats , Animals , Spleen/pathology , Rats, Wistar , Interleukin-10 , Tumor Necrosis Factor-alpha/pharmacology , Diarrhea/drug therapy , Diarrhea/pathology , Bacteria , Immunoglobulin A, Secretory/pharmacology , Lactates/pharmacology , Water/pharmacology
3.
Zhongguo Zhen Jiu ; 43(1): 40-4, 2023 Jan 01.
Article in Chinese | MEDLINE | ID: mdl-36633238

ABSTRACT

OBJECTIVE: To observe the therapeutic effect of governor vessel moxibustion combined with wenyang yiqi qiwei decoction on erectile dysfunction (ED) with spleen-kidney deficiency and to explore the possible mechanism. METHODS: A total of 130 ED patients with spleen-kidney deficiency were randomized into an observation group (65 cases, 2 cases dropped off) and a control group (65 cases, 3 cases dropped off). The control group was given wenyang yiqi qiwei decoction orally, one dose daily. On the basis of the treatment in the control group, governor vessel moxibustion was applied from Dazhui (GV 14) to Yaoshu (GV 2) in the observation group, 110 min a time, once a day. The treatment of 4 weeks was required in both groups. Before and after treatment, 5-question international index of erectile function (IIEF-5) score, erection quality scale (EQS) score, erectile hardness assessment (EHS) score, TCM syndrome score, serum testosterone (T) level and vascular endothelial function indexes (prostaglandin I2 [PGI2], endothelin-1 [ET-1] and nitric oxide [NO] levels) were observed respectively, and the clinical efficacy was evaluated in both groups. RESULTS: After treatment, the scores of IIEF-5, EQS, EHS and serum levels of T, PGI2, NO were increased compared before treatment (P<0.01), the TCM syndrome scores and serum ET-1 levels were decreased compared before treatment (P<0.01) in the two groups; the scores of IIEF-5, EQS, EHS and serum levels of T, PGI2, NO in the observation group were higher than those in the control group (P<0.01, P<0.05), the TCM syndrome score and serum ET-1 level were lower than those in the control group (P<0.01, P<0.05). The total effective rate was 88.9% (56/63) in the observation group, which was superior to 74.2% (46/62) in the control group (P<0.05). CONCLUSION: Governor vessel moxibustion combined with wenyang yiqi qiwei decoction can improve the erectile function and increase the erection hardness and quality in ED patients with spleen-kidney deficiency, its mechanism may relate to improving serum T level and vascular endothelial function.


Subject(s)
Drugs, Chinese Herbal , Erectile Dysfunction , Kidney Diseases , Moxibustion , Splenic Diseases , Humans , Male , Administration, Oral , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/therapeutic use , Erectile Dysfunction/etiology , Erectile Dysfunction/therapy , Kidney/pathology , Kidney Diseases/complications , Spleen/pathology , Splenic Diseases/complications , Testosterone/blood , Combined Modality Therapy
4.
Article in Chinese | WPRIM | ID: wpr-969945

ABSTRACT

OBJECTIVE@#To observe the therapeutic effect of governor vessel moxibustion combined with wenyang yiqi qiwei decoction on erectile dysfunction (ED) with spleen-kidney deficiency and to explore the possible mechanism.@*METHODS@#A total of 130 ED patients with spleen-kidney deficiency were randomized into an observation group (65 cases, 2 cases dropped off) and a control group (65 cases, 3 cases dropped off). The control group was given wenyang yiqi qiwei decoction orally, one dose daily. On the basis of the treatment in the control group, governor vessel moxibustion was applied from Dazhui (GV 14) to Yaoshu (GV 2) in the observation group, 110 min a time, once a day. The treatment of 4 weeks was required in both groups. Before and after treatment, 5-question international index of erectile function (IIEF-5) score, erection quality scale (EQS) score, erectile hardness assessment (EHS) score, TCM syndrome score, serum testosterone (T) level and vascular endothelial function indexes (prostaglandin I2 [PGI2], endothelin-1 [ET-1] and nitric oxide [NO] levels) were observed respectively, and the clinical efficacy was evaluated in both groups.@*RESULTS@#After treatment, the scores of IIEF-5, EQS, EHS and serum levels of T, PGI2, NO were increased compared before treatment (P<0.01), the TCM syndrome scores and serum ET-1 levels were decreased compared before treatment (P<0.01) in the two groups; the scores of IIEF-5, EQS, EHS and serum levels of T, PGI2, NO in the observation group were higher than those in the control group (P<0.01, P<0.05), the TCM syndrome score and serum ET-1 level were lower than those in the control group (P<0.01, P<0.05). The total effective rate was 88.9% (56/63) in the observation group, which was superior to 74.2% (46/62) in the control group (P<0.05).@*CONCLUSION@#Governor vessel moxibustion combined with wenyang yiqi qiwei decoction can improve the erectile function and increase the erection hardness and quality in ED patients with spleen-kidney deficiency, its mechanism may relate to improving serum T level and vascular endothelial function.


Subject(s)
Humans , Male , Administration, Oral , Drugs, Chinese Herbal/therapeutic use , Erectile Dysfunction/therapy , Kidney/pathology , Kidney Diseases/complications , Moxibustion , Spleen/pathology , Splenic Diseases/complications , Testosterone/blood , Combined Modality Therapy
5.
Sci Rep ; 12(1): 15791, 2022 09 22.
Article in English | MEDLINE | ID: mdl-36138037

ABSTRACT

A cat was presented with mast cell tumors (MCTs) of the skin and spleen. During the initial diagnosis, the exon 8 mutation of c-KIT was detected in the masses from skin and spleen by a commercial laboratory test. Consequently, treatment with toceranib was started. After complete remission, because of recurrence on day 117, the spleen and skin tumors were removed, but the cat eventually died on day 191. The analysis of ten cDNA clones of the c-KIT gene cloned from the surgically removed spleen revealed that seven different cDNA patterns were included, indicating the heterogeneity of this gene in the splenic MCT. The seven cDNA nucleotide patterns can be classified into four protein sequence patterns. In addition to the previously known mutations in exon 8, we identified novel mutations in exons 9, 10, and 18; four amino acids deletion in exon 9, and a point mutation in exons 10 and 18. Mouse IL-3-dependent cell line, Ba/F3, was transduced with these mutant clones, and c-KIT phosphorylation and proliferation assays were performed. We found that certain mutations affected the c-KIT phosphorylation status and cell proliferation. This suggests that heterogeneity among the population of tumor cells exists in MCTs, and that the dominant clones of this heterogeneity may contribute to the subsequent tumor cell growth.


Subject(s)
Myeloproliferative Disorders , Spleen , Amino Acids/genetics , Animals , Cat Diseases/genetics , Cats , Cell Proliferation/genetics , DNA, Complementary , Interleukin-3/genetics , Mast Cells/metabolism , Mice , Mutation , Myeloproliferative Disorders/genetics , Myeloproliferative Disorders/veterinary , Nucleotides , Proto-Oncogene Proteins c-kit/metabolism , Receptor Protein-Tyrosine Kinases/genetics , Spleen/pathology
6.
Contrast Media Mol Imaging ; 2022: 9316873, 2022.
Article in English | MEDLINE | ID: mdl-35800233

ABSTRACT

Objective: To explore the efficacy of combined therapy of Regorafenib with detoxicating and stasis softening Chinese herbal spleen tonics (DSS-splenic tonics) in mid-/late-stage hepatocellular carcinoma. Methods: Retrospective observational data of 120 patients were obtained, 60 of which received combined therapy of DSS-splenic tonics and regorafenib. Adverse event, overall survival (OS), and time-to-progress (TTP) were analyzed. Synergistic effect of DSS-spleen tonics was found and validated in human hepatocellular carcinoma HCCLM3 cell line and xenograft mouse models. Results: Combination of regorafenib and DSS-splenic tonics also slightly extended the TTP and OS compared with treatment of regorafenib alone, suggesting DSS-splenic tonics has synergistic effect with regorafenib. Both Regorafenib and DSS-spleen tonics exerted inhibitory effect on cell viability and invasion capability of HCCLM3 cells, and combining both could enhance the antitumor effect. At molecular level, we found that VEGF, HIF-1α, MVD, and VEGF2 were all suppressed by regorafenib and DSS-splenic tonics. These results suggest that DSS-spleen tonics function synergistically with regorafenib in HCC by enhancing the regulation of regorafenib on VEGF, MMP-2, HIF-1α, and MVD, and may diminish angiogenesis during HCC progression. Conclusion: DSS-spleen tonics could exert synergistic antitumor effect with regorafenib via targeting VEGF.


Subject(s)
Antineoplastic Agents , Carcinoma, Hepatocellular , Liver Neoplasms , Animals , Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/pathology , China , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/pathology , Mice , Niacinamide/therapeutic use , Phenylurea Compounds/pharmacology , Phenylurea Compounds/therapeutic use , Pyridines , Retrospective Studies , Sorafenib/pharmacology , Sorafenib/therapeutic use , Spleen/pathology , Vascular Endothelial Growth Factor A
7.
Oxid Med Cell Longev ; 2022: 5559151, 2022.
Article in English | MEDLINE | ID: mdl-35126816

ABSTRACT

BACKGROUND: The Caoguo-4 decoction, a classical Mongolian medicine formula, is widely used to treat spleen deficiency diarrhea (SDD) in Mongolian for decades. Previously, the Caoguo-4 decoction volatile oil has been confirmed to be effective in ameliorating symptoms of spleen deficiency diarrhea in an animal model. However, the underlying mechanism of the Caoguo-4 decoction volatile oil is yet to be established. The aim of the current study was to investigate the antidiarrheal effects and mechanism of the Caoguo-4 decoction volatile oil. METHOD: Wistar rats were randomly divided into 5 groups of 10 animals including control, model, positive, Caoguo-4 decoction, and Caoguo-4 decoction volatile oil groups (10 rats in each group). All the rats, besides those in the control group, were induced to develop SDD by a bitter-cold purgation method with Xiaochengqi decoction. The antidiarrheal effect of Caoguo-4 decoction volatile oil was evaluated by pathological section, serum D-xylose and AMS content, plasma MTL content, and gut microbiota analysis via 16S rRNA sequencing. RESULTS: The results showed that the developed SDD rat model (model group) had decreased food intake, increased weight loss, soft stool, and bad hair color. When compared with the control group, serum was significantly reduced serum D-xylose and AML but increased MTL levels in the model group (p < 0.05). However, after treatment with either the Caoguo-4 decoction (the decoction group) or Smecta (the positive group) or volatile oil from the Caoguo-4 decoction (the volatile oil group), a significant increase in the serum D-xylose levels was observed. Additionally, AML levels significantly increased in the positive and volatile oil groups, and MTL levels significantly decreased in the decoction and volatile oil groups, when compared with the model group (p < 0.05). The pathological changes of the intestinal mucosa showed that the structure of the epithelium in the villi of the small intestine was affected, deformed, and incomplete in the model group when compared with the control group. However, either the decoction group or the volatile oil group recovered the villous morphology. The results of OTU analysis and alpha diversity analysis of intestinal bacteria showed that the intestinal microbiota of the SDD model rats showed an obvious decrease in richness and diversity of intestinal microbiota. But the intervention treatment of decoction and volatile oil could significantly recover the richness and diversity of intestinal microbiota. CONCLUSION: The intestinal microbiota destroyed in SDD modelling could be significantly improved by the Caoguo-4 decoction volatile oils, which provides reference for clinical medication.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Gastrointestinal Microbiome/drug effects , Oils, Volatile/pharmacology , Amylases/metabolism , Animals , Bacteroidetes/genetics , Bacteroidetes/isolation & purification , Cyanobacteria/genetics , Cyanobacteria/isolation & purification , Diarrhea/drug therapy , Disease Models, Animal , Drugs, Chinese Herbal/therapeutic use , Feces/microbiology , Intestinal Mucosa/drug effects , Intestinal Mucosa/pathology , Male , Oils, Volatile/therapeutic use , RNA, Ribosomal, 16S/analysis , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/metabolism , Rats , Rats, Wistar , Spleen/pathology , Xylose/blood
8.
Mol Immunol ; 142: 63-75, 2022 02.
Article in English | MEDLINE | ID: mdl-34965485

ABSTRACT

Severe acute pancreatitis (SAP) is complicated by systemic inflammatory response syndrome and multiple organ dysfunction, the disease will eventually result in death in almost half of the case. The spleen, as the largest immune organ adjacent to the pancreas, is prone to damage in SAP, thereby aggravating the damage of other organs and increasing mortality. However, to date, the research on the mechanism and treatment of spleen injury caused by SAP is still in its infancy. Herein, we investigated the mechanism of spleen injury, and explored the application potential of tuftsin for relieving spleen damage in SAP mice. Firstly, SAP mice model was constructed via the retrograde infusion of 3.5 % sodium taurocholate into the biliopancreatic duct. Then, we proved that the up-regulation of Toll-like receptor 4 (TLR4) in spleen would lead to the accumulation of reactive oxygen species (ROS) and mitochondrial dysfunction under SAP conditions. The splenic ROS and mitochondrial dysfunction could be improved by N-acetylcysteine (NAC) treatment or knocking out TLR4 in SAP mice. Meanwhile, we found that NAC treatment could also improve the autophagy of spleen tissue, suggesting that splenic ROS may affect impaired autophagy, causing the accumulation of damaged mitochondria, aggravating spleen damage. Furthermore, we verified the mechanism of spleen injury is caused by splenic ROS affecting PI3K/p-AKT/mTOR pathway-mediated autophagy. In addition, we detected the spleen injury caused by SAP could decrease the concentration of tuftsin in the serum of mice. Whereas, exogenous supplementation of tuftsin ameliorated the pathological damage, ROS accumulation, impaired autophagy, inflammation expression and apoptosis in damaged spleen. In summary, we verified the new mechanism of SAP-caused spleen damage that TLR4-induced ROS provoked mitophagy impairment and mitochondrial dysfunction in spleen via PI3K/p-AKT mTOR signaling, and the application potential of tuftsin in treating spleen injury, which might expand novel ideas and methods for the treatment of pancreatitis.


Subject(s)
Mitophagy/physiology , Pancreatitis/pathology , Reactive Oxygen Species/metabolism , Spleen/pathology , Toll-Like Receptor 4/metabolism , Acetylcysteine/pharmacology , Animals , Apoptosis/physiology , Immunologic Factors/therapeutic use , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Mitochondria/pathology , Pancreas/pathology , Pancreatitis/chemically induced , Phosphatidylinositol 3-Kinase/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/physiology , Spleen/injuries , TOR Serine-Threonine Kinases/metabolism , Taurocholic Acid/toxicity , Toll-Like Receptor 4/genetics , Tuftsin/therapeutic use
9.
Cells ; 10(12)2021 11 30.
Article in English | MEDLINE | ID: mdl-34943868

ABSTRACT

We investigated the prophylactic and therapeutic effects of the oral administration of transgenic rice seeds expressing a hypoallergenic Bet v 1 derivative of allergic birch pollen conjunctivitis in mice. Transgenic rice seed depositing a chimeric molecule called TPC7 (tree pollen chimera 7) created by DNA shuffling of Bet v 1 family sequences from birch, alder and hazel in protein bodies of endosperm was generated. BALB/c mice were sensitized to birch pollen in alum and challenged with pollen in eyedrops. They were fed TPC7 transgenic or non-transgenic (control) rice seeds for 14 d before sensitization (prophylactic protocol) or 17 d after sensitization (therapeutic protocol). The clinical score and number of conjunctival eosinophils were significantly lower in TPC7-fed mice than in the control mice based on both the prophylactic and therapeutic protocols. Serum concentration of allergen-specific IgE did not differ between TPC7-fed and control groups in either protocol. Prophylactic administration of TPC7 downregulated the production of IL-4 and IFN-γ, whereas therapeutic administration of TPC7 upregulated the production of IFN-γ by allergen-stimulated splenocytes. Prophylactic or therapeutic oral administration of transgenic rice expressing TPC7 suppressed birch pollen-induced allergic conjunctivitis in mice. Feeding transgenic rice is a potentially effective approach as an allergen-specific immunotherapy for allergic conjunctivitis.


Subject(s)
Allergens/immunology , Betula/adverse effects , Conjunctivitis, Allergic/immunology , Conjunctivitis, Allergic/prevention & control , Desensitization, Immunologic , Oryza/genetics , Pollen/adverse effects , Vaccines, Edible/immunology , Administration, Oral , Animals , Conjunctivitis, Allergic/blood , Immunoglobulin E/blood , Interferon-gamma/metabolism , Interleukin-4/metabolism , Lymph Nodes/pathology , Mice , Mice, Inbred BALB C , Plants, Genetically Modified , Spleen/pathology , T-Lymphocytes, Regulatory/immunology
10.
Toxicol Ind Health ; 37(12): 763-775, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34797179

ABSTRACT

Nanoparticles of iron oxide, with diameters beteween 1 to 100 nm, have notable implications for human health and well being. In the current study, we have investigated the effects of iron oxide nanoparticles (IONP) exposure on general physiology and health of adult Wistar rats. IONP used in the study had spherical shape and average size in the range of 15-20 nm. A total of eight groups of rats were repeatedly injected with 0 (control), 20, 40, and 80 mg IONP per kg body weight intraperitoneally under two different exposure schemes (sub-acute and sub-chronic). IONP exposure caused significant changes in lungs, liver, and kidney indices in both exposure schemes. Sub-acute exposure did not affect body weight gain in treated rats, but longer duration exposure was responsible for significant reduction in body weight. Mesenteries, visceral fatty tissues, and visceral peritoneal membranes demonstrated apparent accumulations of IONP in a dose and time-dependent manner. Hematological analysis showed that total RBC count, hemoglobin content, hematocrit, mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and mean platelet volume (MPV) were not affected by IONP exposure. Total lymphocyte count, however, was elevated in low- and mid-dose treated rats, but not in high-dose group. Serum lactate dehydrogenase (LDH) increased significantly in rats treated with mid and high doses as compared to control. Serum creatinine and blood urea nitrogen levels were also significantly altered in treated rats. Histological study found significant hepatic damage and mild spleen toxicity. Our report suggests that IONP exhibit significant toxicity in rats.


Subject(s)
Ferric Compounds/toxicity , Nanoparticles/toxicity , Animals , Blood Urea Nitrogen , Creatinine/blood , Dose-Response Relationship, Drug , L-Lactate Dehydrogenase/blood , Liver/pathology , Male , Rats, Wistar , Spleen/pathology
11.
Food Funct ; 12(22): 11214-11228, 2021 Nov 15.
Article in English | MEDLINE | ID: mdl-34647565

ABSTRACT

The thymus and spleen are the main reservoir for T lymphocytes, which can regulate the innate immune response and provide protection against pathogens and tissue damage. Oxidative stress, excessive inflammation, abnormal autophagy and endoplasmic reticulum (ER) stress can all lead to dysfunction of the thymus and spleen. This study was conducted to investigate the effect of maternal 2-hydroxy-4-methylselenobutanoic acid (HMSeBA, an organic Se source) supplementation during pregnancy on the selenoprotein expression, inflammation, ER stress and autophagy of their young offspring's thymus and spleen. Thirty sows were randomly assigned to receive one of the following two diets during gestation: control diet (control, basal diet, n = 15) or HMSeBA supplemented diet (HMSeBA, basal diet +0.3 mg Se kg-1 as HMSeBA, n = 15). Tissues of thymus and spleen were collected from the offspring at birth and weaning after the lipopolysaccharide challenge. Results showed that maternal HMSeBA supplementation significantly up-regulated the gene expression of selenoproteins in the thymus and spleen of newborn piglets compared with the basal diet (p < 0.05), as well as the protein abundance of GPX1 and GPX4 (p < 0.05). In addition, maternal HMSeBA supplementation effectively decreased the expression of inflammation and autophagy related proteins in the thymus and spleen of newborn piglets as compared with the control group (p < 0.05). In weaning piglets, maternal HMSeBA significantly increased the antioxidative capacity of thymus and spleen (p < 0.05), and reversed LPS induced MDA content as compared with the control group (p < 0.05). Furthermore, maternal HMSeBA supplementation during gestation reversed the activation of the MAPK/NF-κB pathway, ER stress and autophagy induced by the LPS challenge in the thymus and spleen of weaning piglets (p < 0.05). In conclusion, maternal HMSeBA supplementation during gestation could decrease the level of inflammation, autophagy and ER stress in the thymus and spleen of young offspring by improving the antioxidative capacity and selenoprotein expression in these tissues. Therefore, maternal HMSeBA supplementation during gestation might be beneficial for the immune function of their offspring by alleviating inflammation, autophagy and ER stress levels in the thymus and spleen. This study showed more evidence for the function of Se on mater-offspring integrated nutrition.


Subject(s)
Autophagy/drug effects , Endoplasmic Reticulum Stress/drug effects , Selenium , Selenoproteins/metabolism , Animals , Animals, Newborn , Dietary Supplements , Female , Inflammation/chemically induced , Inflammation/metabolism , Lipopolysaccharides , Male , Selenium/administration & dosage , Selenium/pharmacology , Spleen/drug effects , Spleen/metabolism , Spleen/pathology , Swine , Thymus Gland/drug effects , Thymus Gland/metabolism , Thymus Gland/pathology , Weaning
12.
Biomed Res Int ; 2021: 6692772, 2021.
Article in English | MEDLINE | ID: mdl-34595240

ABSTRACT

Asthma is a T helper 2 (Th2) cell-associated chronic inflammatory diseases characterized with airway obstruction, increased mucus production, and eosinophil infiltration. Conventional medications for asthma treatment cannot fully control the symptoms, and potential side effects are also the concerns. Thus, complement or alternative medicine (CAM) became a new option for asthma management. Ding Chuan Tang (DCT) is a traditional Chinese herbal decoction applied mainly for patients with coughing, wheezing, chest tightness, and asthma. Previously, DCT has been proved to improve children airway hyperresponsiveness (AHR) in a randomized and double-blind clinical trial. However, the mechanisms of how DCT alleviates AHR remain unclear. Since asthmatic features such as eosinophil infiltration, IgE production, and mucus accumulation are relative with Th2 responses, we hypothesized that DCT may attenuate asthma symptoms through regulating Th2 cells. Ovalbumin (OVA) was used as a stimulant to sensitize BALB/c mice to establish an asthmatic model. AHR was detected one day before sacrifice. BALF and serum were collected for immune cell counting and antibody analysis. Splenocytes were cultured with OVA in order to determine Th2 cytokine production. Lung tissues were collected for histological and gene expression analyses. Our data reveal that DCT can attenuate AHR and eosinophil accumulation in the 30-day sensitization asthmatic model. Histological results demonstrated that DCT can reduce cell infiltration and mucus production in peribronchial and perivascular site. In OVA-stimulated splenocyte cultures, a significant reduction of IL-5 and IL-13 in DCT-treated mice suggests that DCT may alleviate Th2 responses. In conclusion, the current study demonstrates that DCT has the potential to suppress allergic responses through the reduction of mucus production, eosinophil infiltration, and Th2 activity in asthma.


Subject(s)
Asthma/drug therapy , Asthma/immunology , Eosinophils/physiology , Immunization , Ovalbumin/immunology , Plant Extracts/therapeutic use , Pneumonia/drug therapy , Pneumonia/immunology , Animals , Asthma/blood , Asthma/physiopathology , Bronchial Hyperreactivity/blood , Bronchial Hyperreactivity/complications , Bronchial Hyperreactivity/physiopathology , Bronchoalveolar Lavage Fluid , Down-Regulation , Eosinophils/drug effects , Female , Immunoglobulin E/blood , Interleukin-13/biosynthesis , Interleukin-5/biosynthesis , Mice, Inbred BALB C , Mucus/metabolism , Plant Extracts/pharmacology , Pneumonia/complications , Pneumonia/physiopathology , Spleen/pathology
13.
Pak J Pharm Sci ; 34(3): 971-979, 2021 May.
Article in English | MEDLINE | ID: mdl-34602421

ABSTRACT

Aconitine, the main component in Radix Aconiti Lateralis Preparata, not only exerts the anti-tumor effect on Hepatocellular Carcinoma (HCC) but also damages on immune system. In the present study, Crude Monkshood Polysaccharide (CMP), another one natural composition component originated from the same herbal with aconitine, combined with aconitine to investigate the effects on HCC and immunity in vitro and in vivo. The combination of CMP and aconitine enhanced the ability of the immunocyte to kill the tumor cell in vitro and had an additive effect on anti-HCC in vivo. Aconitine-CMP in combination improved the spleen weights, spleen index, thymus weights, thymus index. Elevated CD4+ T and CD8+ T cells and macrophages in spleen, decreased serum IL-6 level and increased serum IFN-γ and TNF-α levels were observed in mice treated with the combination of aconitine and CMP compare with control group (P<0.05). Our results showed that the combination of aconitine and CMP exerts anti-tumor effect by directly killing tumor cells and enhancing the anti-tumor immune responses, which further implies that chemotherapy drugs combined with Chinese medicine immunopotentiator maybe a feasible and effective strategy for HCC.


Subject(s)
Aconitine/pharmacology , Aconitum , Carcinoma, Hepatocellular/immunology , Cell Proliferation/drug effects , Liver Neoplasms/immunology , Plant Extracts/pharmacology , Adjuvants, Immunologic/pharmacology , Animals , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Carcinoma, Hepatocellular/metabolism , Cell Line, Tumor , In Vitro Techniques , Interferon-gamma/drug effects , Interferon-gamma/immunology , Interferon-gamma/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Liver Neoplasms/metabolism , Lymphocytes/drug effects , Lymphocytes/immunology , Macrophages/drug effects , Macrophages/immunology , Mice , Neoplasm Transplantation , Organ Size/drug effects , Polysaccharides/pharmacology , Spleen/drug effects , Spleen/immunology , Spleen/pathology , Thymus Gland/drug effects , Thymus Gland/immunology , Thymus Gland/pathology , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism
14.
Front Immunol ; 12: 713799, 2021.
Article in English | MEDLINE | ID: mdl-34539643

ABSTRACT

Rheumatoid arthritis (RA) is significantly associated with glycolysis. This study used 2-deoxy-D-glucose (2-DG), an inhibitor of glycolysis, to treat rats with collagen-induced arthritis (CIA) and investigate the metabolic regulatory mechanism of glycolysis in the disease. 2-DG significantly alleviated CIA. Metabolomics and transcriptomics, as well as their integrative analysis, detected significant changes in the pathways of bile secretion, cholesterol and linoleic acid metabolism in the plasma, liver and spleen during the CIA process and the opposite changes following 2-DG treatment, whereas the expression of the genes regulating these metabolic pathways were changed only in the spleen. In the rat liver, levels of (S)-5-diphosphomevalonic acid in the terpenoid backbone biosynthesis pathway were significantly decreased during CIA progression and increased following 2-DG treatment, and levels of taurochenodeoxycholic acid in the pentose and glucuronate interconversions pathway showed the opposite results. In the spleen, levels of 3-methoxy-4-hydroxyphenylglycol glucuronide in bile secretion and 12(S)-leukotriene B4 in arachidonic acid metabolism were significantly decreased during CIA progression and increased following 2-DG treatment. The changes in the gene-metabolite network of bile secretion in the spleen correlated with a decreased plasma L-acetylcarnitine level in CIA rats and an increase following 2-DG treatment. Our analysis suggests the involvement of spleen and liver metabolism in CIA under the control of glycolysis.


Subject(s)
Arthritis, Experimental/etiology , Arthritis, Experimental/metabolism , Energy Metabolism , Glucose/metabolism , Liver/immunology , Liver/metabolism , Spleen/immunology , Spleen/metabolism , Animals , Arthritis, Experimental/pathology , Computational Biology/methods , Cytokines/metabolism , Gene Expression Profiling , Glycolysis , Liver/pathology , Lymphocyte Count , Lymphocyte Subsets/immunology , Lymphocyte Subsets/metabolism , Lymphocyte Subsets/pathology , Metabolomics/methods , Rats , Spleen/pathology
15.
J Ethnopharmacol ; 280: 114397, 2021 Nov 15.
Article in English | MEDLINE | ID: mdl-34245831

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Spleen-invigorating pills (SIP) are composed of Codonopsis, fried Atractylodes, tangerine peel, Fructus aurantii immaturus (fried), fried hawthorn, and colored malt. SIP strengthens the spleen and increases appetite and is often used as a chemotherapy adjuvant. AIM OF THE STUDY: We aimed to explore the protective effects and mechanism of action for SIP on mouse bone marrow stromal cells (OP9) injured by 5-fluorouracil (5-FU). MATERIALS AND METHODS: The effects of SIP on OP9 cells injured by 5-FU were evaluated, and high-performance liquid chromatography (HPLC) was used as a quality control method. The experiments were divided into a control group, a model group, an epidermal growth factor (EGF) treatment group, and an SIP treatment group. The cell survival rate, apoptotic cell morphology, cell apoptosis rate, and the contents of caspase 3 were evaluated to determine the protective effects of SIP in OP9 cells injured by 5-FU. Network pharmacology was used to predict the mechanism through which SIP mediates anti-chemotherapy damage. The nitric oxide (NO) and nitric oxide synthase (iNOS) levels and the expression of nuclear factor erythroid-2 related factor 2 (Nrf2) and p62 protein were detected to explore the mechanism through which SIP mediates anti-chemotherapy damage through the regulation of oxidative stress. RESULTS: Cell counting kit-8 (CCK8) detection showed that 5-FU reduced OP9 cell survival, and SIP blocked the inhibition of OP9 cell growth induced by 5-FU. When OP9 cells were treated with both SIP (10 g L-1) and 5-FU (2.5 × 10-2 g L-1) for 24 h, compared with the model group, the early apoptosis rates significantly decreased, and the activity of caspase 3 was significantly reduced. The results of network pharmacology and Western blot showed that compared with the model group, in the SIP group, the NO levels decreased, iNOS release decreased, and the expression of Nrf2 and p62 proteins increased. CONCLUSION: The protective effects of SIP on OP9 cells injured by 5-FU were significant. SIP may play a cytoprotective role by mediating changes in oxidative stress-related proteins. The specific mechanism of action through which SIP mediates these effects remains to be further studied.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Fluorouracil/toxicity , Mesenchymal Stem Cells/drug effects , Spleen/drug effects , Animals , Antimetabolites, Antineoplastic/toxicity , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Mesenchymal Stem Cells/pathology , Mice , Network Pharmacology , Nitric Oxide Synthase Type II/metabolism , Oxidative Stress/drug effects , Spleen/cytology , Spleen/pathology
16.
J Med Microbiol ; 70(6)2021 Jun.
Article in English | MEDLINE | ID: mdl-34115583

ABSTRACT

Introduction. Leishmaniasis is a neglected tropical and subtropical disease caused by over 20 protozoan species.Hypothesis. Treatment of this complex disease with traditional synthetic drugs is a major challenge worldwide. Natural constituents are unique candidates for future therapeutic development.Aim. This study aimed to assess the in vivo anti-leishmanial effect of the Gossypium hirsutum extract, and its fractions compared to the standard drug (Glucantime, MA) in a murine model and explore the mechanism of action.Methodology. Footpads of BALB/c mice were infected with stationary phase promastigotes and treated topically and intraperitoneally with G. hirsutum extract, its fractions, or Glucantime, 4 weeks post-infection. The extract and fractions were prepared using the Soxhlet apparatus with chloroform followed by the column procedure.Results. The crude extract significantly decreased the footpad parasite load and lesion size compared to the untreated control group (P<0.05), as revealed by dilution assay, quantitative real-time PCR, and histopathological analyses. The primary mode of action involved an immunomodulatory role towards the Th1 response in the up-regulation of IFN-γ and IL-12 and the suppression of IL-10 gene expression profiling against cutaneous leishmaniasis caused by Leishmania major.Conclusion. This finding suggests that the extract possesses multiple combinatory effects of diverse bioactive phytochemical compositions that exert its mechanisms of action through agonistic-synergistic interactions. The topical extract formulation could be a suitable and unique candidate for future investigation and pharmacological development. Further studies are crucial to evaluate the therapeutic potentials of the extract alone and in combination with conventional drugs using clinical settings.


Subject(s)
Antiprotozoal Agents/therapeutic use , Gossypium , Leishmania major/drug effects , Leishmaniasis, Cutaneous/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Administration, Topical , Animals , Antiprotozoal Agents/pharmacology , Female , Injections, Intraperitoneal , Interferon-gamma/genetics , Interferon-gamma/metabolism , Interleukin-10/genetics , Interleukin-12 Subunit p40/genetics , Interleukin-12 Subunit p40/metabolism , Leishmania major/physiology , Leishmaniasis, Cutaneous/parasitology , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/physiopathology , Lymph Nodes/pathology , Meglumine Antimoniate/administration & dosage , Meglumine Antimoniate/therapeutic use , Mice , Mice, Inbred BALB C , Parasite Load , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Spleen/parasitology , Spleen/pathology , Th1 Cells/immunology , Transcriptome
17.
J Mol Histol ; 52(4): 751-766, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34050395

ABSTRACT

Curcumin as active metal chelating and antioxidant agent has a potential role in metal reduction and free radicals' neutralization in tissues. Of note, long-term administration of high fat diet (HFD) is considered as a main factor of blood serum iron deficiency. This study aimed to investigate the biodistribution profiles of iron in the spleen after long-term administration of HFD along with iron supplementation. Furthermore, the ameliorative role of curcumin to reduce iron accumulation level and improve the histological abnormalities produced by iron in spleen will be evaluated in the rats. Treated albino rats of this experiment were divided into six groups. Group I was a control group where group II was treated with HFD. Group III and group IV were treated with combination of HFD and curcumin or HFD and iron supplement respectively. Additionally, group V and group VI were treated with combination of HFD, iron supplement and curcumin or curcumin only respectively. Mainly histological analysis was used to investigate iron biodistribution and induced abnormalities in spleen under light microscope. The histochemical specific staining of iron in the spleen showed different biodistribution profiles of iron in the spleen. Administration of the HFD or HFD and iron supplementation increased the iron accumulation in the spleen. Where, curcumin administration with HFD (Group III) or with HFD and iron supplementation (Group V) significantly reduced the iron levels in the spleen. The splenic tissue inflammation, cellular apoptosis and fibrosis produced by higher iron accumulation was ameliorated after administration of curcumin supplementation as shown in the animals treated with HFD/curcumin (Group III) or HFD/iron supplement/curcumin (Group V). This study recommended that, it is preferable to use iron supplementation along with curcumin supplement for less than 4 months to avoid additional iron accumulation in the healthy organs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Curcumin/administration & dosage , Diet, High-Fat , Iron/metabolism , Spleen/metabolism , Animals , Dietary Supplements , Ferritins/blood , Fibrosis , Hepcidins/blood , Iron/administration & dosage , Lipids/blood , Male , Rats , Spleen/pathology , Tissue Distribution
18.
Molecules ; 26(9)2021 Apr 30.
Article in English | MEDLINE | ID: mdl-33946346

ABSTRACT

Colitis causes destruction of the intestinal mucus layer and increases intestinal inflammation. The use of antioxidants and anti-inflammatory agents derived from natural sources has been recently highlighted as a new approach for the treatment of colitis. Oxyresveratrol (OXY) is an antioxidant known to have various beneficial effects on human health, such as anti-inflammatory, antibacterial activity, and antiviral activity. The aim of this study was to investigate the therapeutic effect of OXY in rats with dextran sulfate sodium (DSS)-induced acute colitis. OXY ameliorated DSS-induced colitis and repaired damaged intestinal mucosa. OXY downregulated the expression of pro-inflammatory cytokine genes (TNF-α, IL-6, and IL-1ß) and chemokine gene MCP-1, while promoting the production of anti-inflammatory cytokine IL-10. OXY treatment also suppressed inflammation via inhibiting cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression in the colon, as well as the activity of myeloperoxidase (MPO). OXY exhibited anti-apoptotic effects, shifting the Bax/Bcl-2 balance. In conclusion, OXY might improve DSS-induced colitis by restoring the intestinal mucus layer and reducing inflammation within the intestine.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Dextran Sulfate/adverse effects , Plant Extracts/pharmacology , Stilbenes/pharmacology , Animals , Biomarkers , Colitis/drug therapy , Colitis/etiology , Colitis/metabolism , Colon/drug effects , Colon/metabolism , Colon/pathology , Cytokines/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Gene Expression , Humans , Inflammation Mediators/metabolism , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Nitric Oxide Synthase Type II/metabolism , Organ Size/drug effects , Rats , Spleen/drug effects , Spleen/metabolism , Spleen/pathology
19.
Tissue Cell ; 72: 101533, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33838352

ABSTRACT

Methotrexate (MTX) is a chemotherapeutic agent used for cancer and autoimmune disorders. MTX may cause multi-organ affections. However, few studies examined MTX-induced splenic suppression and therapeutic modalities against it. This is the first study to explore the efficacy of omega-3 fatty acids; Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) against MTX-induced splenic suppression and its effect on splenic macrophages and lymphocytes. Five groups of Sprague Dawley rats were used. Group 1 received saline; group 2: omega-3 only; group 3: a single dose of MTX (20 mg/kg); groups 4 and 5: MTX (20 mg/kg) + either omega-3 (150) or (300 mg/kg) once daily, respectively, given for two days before MTX and three days after it. Splenic tissues were then removed, evaluated for oxidative stress markers; GSH, MDA, and for mRNA expression of the apoptotic marker caspase-3, the anti-apoptotic marker Bcl-2 and the inflammatory cytokine TNFα. Moreover, H&E stain, Prussian blue stain for iron, and immunohistochemical staining for TNFα, T lymphocyte marker; CD3, B lymphocyte marker; CD20, and macrophage marker; CD68, were performed with morphometric analysis. EPA and DHA could decrease the MTX-induced increase in the histopathological injury score, splenic hemosiderin, splenic MDA, mRNA expression of TNFα, caspase-3 and could increase the MTX-induced decrease in Splenic GSH and mRNA expression for Bcl-2. It also decreased the MTX-induced elevation in the immunopositive area of TNFα, and increased the area percentage of CD3+, CD20+ and CD68+ cells. Therefore, omega-3 can be a promising adjuvant to help MTX action with prevention of its deleterious effects on spleen.


Subject(s)
Antigens, CD/metabolism , Apoptosis , B-Lymphocytes/metabolism , Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Macrophages/metabolism , Methotrexate/adverse effects , T-Lymphocytes/metabolism , Animals , Apoptosis/drug effects , B-Lymphocytes/drug effects , Caspase 3/metabolism , Glutathione/metabolism , Macrophages/drug effects , Male , Malondialdehyde/metabolism , Oxidative Stress/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats, Sprague-Dawley , Spleen/drug effects , Spleen/immunology , Spleen/pathology , T-Lymphocytes/drug effects , Tumor Necrosis Factor-alpha/metabolism
20.
J Ethnopharmacol ; 276: 114147, 2021 Aug 10.
Article in English | MEDLINE | ID: mdl-33930492

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Some local communities in Cote d'Ivoire use the mushroom Termitomyces schimperi combined with kaolin (TSK) to manage various cancers in patients. However, there is a paucity of data on toxicity, mutagenicity and trace metal constituent of TSK. AIM OF THE STUDY: We sought to investigate the acute and sub-chronic toxicities, mutagenic potential, and trace metal constituents of TSK. MATERIALS AND METHODS: To assess acute toxicity, single doses (1000, 3000 and 5000 mg/kg) of aqueous extract of TSK were administrated per os to Sprague Dawley (SD) rats on Day 1. The rats were then monitored for 13 consecutive days. Sub-chronic toxicity was evaluated by daily administration of 200 and 500 mg/kg of the extract per os for 90 consecutive days. SD rats used as control received distilled water. Signs of toxicity, changes in body weight and mortality were monitored. After the aforementioned monitoring processes, rats were sacrificed and blood collected for full blood count and biochemistry analysis. Animal organs were also collected for histopathological examination. The mutagenic potential of the aqueous extract of TSK (10000 µg/mL) on TA98 Salmonella typhimurium was estimated. Additionally, energy-dispersive X-ray fluorescence (ED-XRF) method was employed to determine trace metal constituents of TSK. RESULTS: Single-dose administration of 5000 mg/kg of TSK did not cause any death in the SD rats; thus, LD50 was above 5000 mg/kg. Administration of 1000 and 3000 mg/kg of the aqueous extract of TSK did not cause any significant change in behaviour and body weight of SD rats during the 14-day monitoring period. However, the mean corpuscular volume and the mean corpuscular haemoglobin concentration increased significantly (p < 0.01) among rats administered 1000 and 3000 mg/kg of TSK. There was a significant increase (p < 0.0001) in alanine transaminase levels in rats administered 1000 and 3000 mg/kg of TSK extract compared with control. Conversely, there was a significant decrease (p=0.0122) in serum creatine level among rats administered 1000 and 3000 mg/kg of TSK extract compared with control. After 14 days, there were minimal changes with isolated organs of TSK-treated and control rats. Furthermore, 90-day treatment with extract of TSK caused no significant change in parameters assessed. TSK induced frameshift gene mutation in S. typhimurium before (p < 0.05) and after metabolic activation (p < 0.001). Elemental analysis of TSK revealed the presence of toxic (aluminium) or potentially toxic (silver, rabidium, titanium and zirconium) elements. CONCLUSIONS: The aqueous extract of TSK showed no toxicity (acute and sub-chronic) at doses tested. These findings are consistent with the absence of heavy metals (i.e., cadmium) and potentially toxic elements (i.e., uranium) in TSK samples analysed. TSK showed some level of mutagenic potential. Further mutagenic and chronic toxicity studies on TSK are required.


Subject(s)
Kaolin/chemistry , Kaolin/toxicity , Neoplasms/drug therapy , Plant Extracts/chemistry , Plant Extracts/toxicity , Termitomyces/chemistry , Animals , Body Weight/drug effects , Cote d'Ivoire , Heart/drug effects , Kidney/drug effects , Kidney/pathology , Lethal Dose 50 , Liver/drug effects , Liver/pathology , Lung/drug effects , Lung/pathology , Male , Medicine, African Traditional/methods , Mutagenicity Tests , Myocardium/pathology , Organ Size/drug effects , Rats, Sprague-Dawley , Salmonella typhimurium/drug effects , Spleen/drug effects , Spleen/pathology , Time Factors , Toxicity Tests, Subchronic , Trace Elements/analysis
SELECTION OF CITATIONS
SEARCH DETAIL